Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ARDX | ARDELYX, INC. | Chief Patient Officer | $2.61M | -$616K | -19.1% | Aug 26, 2025 |
ELVN, IMRA | Enliven Therapeutics, Inc. | Director | Jun 2, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|